Showing results (121-130 of 154) with videos related to
Sort By:
Pageof 16
Immunotherapy Advances|November 29, 2023
Human infection challenge in the pandemic era and beyond, HIC-Vac annual meeting report, 2022Megan V C Barnes, Anika Mandla, Emma Smith, et al.Immunotherapy Advances|January 15, 2024
Harnessing natural killer cell effector function against cancerMatthew D Blunt, Salim I KhakooImmunotherapy Advances|January 15, 2024
Cancer vaccines: from an immunology perspectiveShania Makker, Charlotte Galley, Clare L BennettImmunotherapy Advances|January 15, 2024
Strategies to overcome low MHC-I expression in paediatric and adult tumoursJ Guillaume, A Perzolli, M BoesImmunotherapy Advances|January 25, 2024
Ex vivo comparative immunogenicity assessment (EVCIA) to determine relative immunogenicity in chronic plaque psoriasis in participants receiving Humira® or undergoing repeated switches between Humira® and AVT02Kathleen Richter, Halimu N Haliduola, Jana Schockaert, et al.Immunotherapy Advances|June 16, 2023
TIGIT-based immunotherapeutics in lung cancerAkshay J Patel, Gary W MiddletonImmunotherapy Advances|August 26, 2022
Predicting clinical response to costimulation blockade in autoimmunityNatalie M Edner, Chun Jing Wang, Lina Petersone, et al.Immunotherapy Advances|August 3, 2022
Combination of genetically engineered T cells and immune checkpoint blockade for the treatment of cancerRafaela Rossetti, Heloísa Brand, Sarah Caroline Gomes Lima, et al.Immunotherapy Advances|August 3, 2022
Target isoforms are an overlooked challenge and opportunity in chimeric antigen receptor cell therapyMike Bogetofte Barnkob, Kristoffer Vitting-Seerup, Lars Rønn OlsenImmunotherapy Advances|August 3, 2022
Oral tolerance as antigen-specific immunotherapyNatália Pinheiro-Rosa, Lícia Torres, Mariana de Almeida Oliveira, et al.Pageof 16